Resources

A 20-year observational study has chronicled notable declines in retinopathy for young patients with type 1 diabetes who receive intensive glycemic control therapy.…

Incretins were a hot topic at this year’s EASD.…

Moving to a better area can reduce patients’ risk for diabetes.…

Eight-week aerobic exercise program had a major impact on fasting blood sugar, HbA1c, high-density lipoprotein, low-density lipoprotein, and quality of life in patients with type 2 diabetes.…

The “muffin test” — an alternative to the oral glucose tolerance test for detecting impaired glucose tolerance….

During my frequent visits to prescribers’ offices I get a chance to see their prescribing habits. When it comes to DPP-4 inhibitors, medical professionals seem to have similar opinions on how to use each of the drugs from this class. But to test this theory, we contacted 25 primary care …

The Mobile Application for Diabetes from Vree gives your patients a full suite of useful tools and provides Interactive Diabetes Education to supplement the advice you give patients, with extensive learning modules that patients can explore at their own pace. Follow this link to find out more and view a …

In this Special Edition on DPP-IV Inhibitors, we present a set of our Homerun Slides focused on The Role of DPP-IV Inhibitors in the Management of Type 2 Diabetes….

The dipeptidyl peptidase-4 (DPP-4) inhibitors are a newer class of oral drugs for the treatment of type 2 diabetes. They inhibit the breakdown of glucagon-like peptide-1 (GLP-1) and increase the incretin effect in patients with type 2 diabetes. In clinical practice they are associated with significant reductions in HbA1c, no …

Foreword to the Second Edition       It is difficult to conceive of a disease more likely to cause psychological problems than diabetes.